{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:20:15Z","timestamp":1780046415488,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T00:00:00Z","timestamp":1275955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00432-010-0911-y","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T11:39:51Z","timestamp":1275910791000},"page":"609-614","source":"Crossref","is-referenced-by-count":26,"title":["Cancer in cohort of HIV-infected population: prevalence and clinical characteristics"],"prefix":"10.1007","volume":"137","author":[{"given":"Yong-xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-en","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ping","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,8]]},"reference":[{"issue":"5","key":"911_CR1","first-page":"1121","volume":"17","author":"G Barbaro","year":"2007","unstructured":"Barbaro G, Barbarini G (2007) HIV infection and cancer in the era of highly active antiretroviral therapy (review). Oncol Rep 17(5):1121\u20131126","journal-title":"Oncol Rep"},{"key":"911_CR2","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","volume":"24","author":"F Boue","year":"2006","unstructured":"Boue F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F et al (2006) Phase II trial of CHOP pius rituximab in patients with HIV-associated non-Hodgkin\u2019s lymphoma. J Clin Oncol 24:4123\u20134128","journal-title":"J Clin Oncol"},{"key":"911_CR3","unstructured":"China CDC (2008) HIV\/AIDS prevalence and challenge in China. China CDC, 12.2"},{"key":"911_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","volume":"97","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Polesel PS, Rickenbach M, Dal Maso L, Keiser O, Kofler A et al (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97:425\u2013432","journal-title":"J Natl Cancer Inst"},{"key":"911_CR5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0959-8049(01)00120-4","volume":"37","author":"L Dal Maso","year":"2001","unstructured":"Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of AIDS-related tumors in developed and developing countries. Eur Cancer 37:1188\u20131201","journal-title":"Eur Cancer"},{"key":"911_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.bjc.6601017","volume":"89","author":"L Dal Maso","year":"2003","unstructured":"Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E et al (2003) Risk of cancer in person with AIDS in Italy, 1985\u20131998. Br J Cancer 89:94\u2013100","journal-title":"Br J Cancer"},{"key":"911_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10552-007-9080-y","volume":"19","author":"AA Dhir","year":"2008","unstructured":"Dhir AA, Sawant S, Dikshit RP, Parikh P, Srivastava S, Badwe R et al (2008) Spectrum of HIV\/AIDS related cancers in India. Cancer Cause Control 19:147\u2013153","journal-title":"Cancer Cause Control"},{"issue":"13","key":"911_CR8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","volume":"285","author":"M Frisch","year":"2001","unstructured":"Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults AIDS-Cancer Match Registry Study Group. JAMA 285(13):1736\u20131745","journal-title":"JAMA"},{"key":"911_CR9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","volume":"351","author":"JJ Goedert","year":"1998","unstructured":"Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH et al (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351:1833\u20131839","journal-title":"Lancet"},{"key":"911_CR10","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2003.01.096","volume":"21","author":"M Herida","year":"2003","unstructured":"Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C et al (2003) Increase of non-AIDS defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus infected patients. J Clin Oncol 21:3447\u20133453","journal-title":"J Clin Oncol"},{"key":"911_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jermal","year":"2009","unstructured":"Jermal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225\u2013249","journal-title":"CA Cancer J Clin"},{"key":"911_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0029-7844(96)00378-X","volume":"89","author":"M Maiman","year":"1997","unstructured":"Maiman M, Fructer R, Serur E, Arrastia CD, Matthews R, Gates EJ et al (1997) Cervical cancer as an AIDS-defining illness. Obstet Gynecol 89:76\u201380","journal-title":"Obstet Gynecol"},{"key":"911_CR13","unstructured":"MMWR (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41:961\u2013962"},{"key":"911_CR14","first-page":"5","volume":"9","author":"J Newcomb-fernandez","year":"2003","unstructured":"Newcomb-fernandez J (2003) Cancer in the HIV-infected population. Res Initial Treat Action 9:5\u201313","journal-title":"Res Initial Treat Action"},{"key":"911_CR15","unstructured":"Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L (eds) (2002) Cancer incidence in five continents, Vol VIII. IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon (France)"},{"key":"911_CR16","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","volume":"17","author":"S Portsmouth","year":"2003","unstructured":"Portsmouth S, Stebbing J, Gill J, Mandalia S, Bower M, Nelson M et al (2003) A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi\u2019s sarcoma. AIDS 17:F17\u2013F22","journal-title":"AIDS"},{"issue":"8","key":"911_CR17","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","volume":"19","author":"L Ratner","year":"2001","unstructured":"Ratner L, Jeannette L, Tang SH, Redden D, Hamzeh F, Hernadier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171\u20132178","journal-title":"J Clin Oncol"},{"key":"911_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/QAI.0b013e31817aebfe","volume":"48","author":"Y Rong-Rong","year":"2008","unstructured":"Rong-Rong Y, Gui Xi-En, Shi-Cheng G, Yong-Xi Z (2008) Interaction of hepatitis B and C Viruses in patients infected with HIV. J Acquir Immune Defic Syndr 48:491\u2013492","journal-title":"J Acquir Immune Defic Syndr"},{"key":"911_CR19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1377\/hlthaff.27.4.1140","volume":"27","author":"R Sherer","year":"2008","unstructured":"Sherer R, Gui X, Zhan F, Teter C, Ping DL, Wykoff RF et al (2008) Rapid antiretroviral therapy scale-up in Hubei province, China. Health Aff (Millwood) 27:1140\u20131147","journal-title":"Health Aff (Millwood)"},{"key":"911_CR20","first-page":"494","volume":"16","author":"Z Siwei","year":"2007","unstructured":"Siwei Z, Wanqing C, Lingzhi G, Guanglin L, Ping L (2007) An annual report: cancer incidence in 35 cancer registries in China, 2003. J Chin Cancer 16:494\u2013507","journal-title":"J Chin Cancer"},{"key":"911_CR21","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/cncr.20622","volume":"101","author":"H Sriplung","year":"2004","unstructured":"Sriplung H, Parkin MD (2004) Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 101:2660\u20132665","journal-title":"Cancer"},{"key":"911_CR22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Munoz A et al (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohor Study (MACS). Lancet 360:1921\u20131927","journal-title":"Lancet"},{"key":"911_CR23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1054\/bjoc.1999.1071","volume":"82","author":"HR Wabinga","year":"2000","unstructured":"Wabinga HR, Parkin DM, Warbwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo Country, Uganda, 1960\u20131997. Br J Cancer 82:1585\u20131592","journal-title":"Br J Cancer"},{"issue":"Suppl","key":"911_CR24","first-page":"S25","volume":"32","author":"P Xiong-ming","year":"2003","unstructured":"Xiong-ming P, Wei-dong W, Xiao-jing K (2003) Clinical and experimental study on thirty-eight patients with classic Kaposi\u2019s sarcoma in the XingJiang Uighur autonomous region. J Clin Dermatol 32(Suppl):S25\u2013S31","journal-title":"J Clin Dermatol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0911-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0911-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T21:55:18Z","timestamp":1559166918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0911-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0911-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,8]]}}}